Live Breaking News & Updates on Hangzhou Zhhongmei Huadong Pharmaceutical Co Ltd

Stay updated with breaking news from Hangzhou zhhongmei huadong pharmaceutical co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Indobufen Noninferior to Aspirin for DAPT After PCI: OPTION

Antiplatelet agent indobufen was noninferior to aspirin in combination with clopidogrel after coronary intervention on both efficacy and safety outcomes, with less mostly minor bleeding. ....

United States , Dipti Itchhaporia , Eric Sheila Samson , University Of California , American Heart Association , German Heart Center Munich , Academic Research Consortium , Vascular Institute , American College Of Cardiology , Drug Administration , American Heart Association Scientific Sessions , Hangzhou Zhhongmei Huadong Pharmaceutical Co Ltd , Fudan University , Shanghai Clinical Research Center , National Medical Products Administration , Zhongshan Hospital , Bleeding Academic Research Consortium , Stefanie Sch , Medscape Cardiology , Sheila Samson , Hoag Heart , American College , Interventional Medicine , Clinical Research Special Fund , Zhongshan Hospital Fudan , Heart Association ,